The Dual PI3K/mToR Inhibitor Omipalisib/GSK2126458 Inhibits Clonogenic Growth in Oncogenically-transformed Cells from Neurocutaneous Melanocytosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The Dual PI3K/mToR Inhibitor Omipalisib/GSK2126458 Inhibits Clonogenic Growth in Oncogenically-transformed Cells from Neurocutaneous Melanocytosis

Published:2018 Issue:4 Volume:15 Page:239-248
ISSN:1109-6535
Container-title:Cancer Genomics - Proteomics
language:en
Short-container-title:Cancer Genomics Proteomics

Author:

BASU DIPANJAN,SALGADO CLÁUDIA M.,BAUER BRUCE,KHAKOO YASMIN,PATEL JANKI R.,HOEHL RYAN M.,BERTOLINI DOMINIQUE M.,ZABEC JOIE,BRZOZOWSKI MORGAN R.,REYES-MÚGICA MIGUEL

Publisher

Anticancer Research USA Inc.

Subject

Cancer Research,Genetics,Molecular Biology,Biochemistry

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alpelisib decreases nevocytes of congenital melanocytic nevi;Journal of the European Academy of Dermatology and Venereology;2023-12-10

2. A clinical and biologic review of congenital melanocytic nevi;The Journal of Dermatology;2023-11-13

3. Three generations of mTOR kinase inhibitors in the activation of the apoptosis process in melanoma cells;Journal of Cell Communication and Signaling;2023-04-25

4. Metabolic Interventions in Tumor Immunity: Focus on Dual Pathway Inhibitors;Cancers;2023-03-29

5. Oral mTOR Inhibition Limits And Reduces Actinic Keratosis And Cutaneous Squamous Cell Carcinoma In A UVB-Induced Mouse Model;2022-11-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP